CoStar Group (CSGP)
(Delayed Data from NSDQ)
$87.50 USD
-0.63 (-0.71%)
Updated May 17, 2024 04:00 PM ET
After-Market: $87.51 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$87.50 USD
-0.63 (-0.71%)
Updated May 17, 2024 04:00 PM ET
After-Market: $87.51 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Zacks News
CoStar Group (CSGP) Q2 Earnings Beat, Revenues Increase Y/Y
by Zacks Equity Research
CoStar's (CSGP) second-quarter 2020 results benefit from robust traffic on Apartments.com and LoopNet marketplaces.
CoStar Group (CSGP) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
CoStar (CSGP) delivered earnings and revenue surprises of 14.71% and 1.82%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate CoStar Group (CSGP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CoStar (CSGP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moderna Rises on Bullish Sentiments for Coronavirus Vaccine
by Zacks Equity Research
Moderna's (MRNA) progress with its coronavirus vaccine is boosting the company's growth prospects. Some analysts expect its coronavirus vaccine to generate more than $5 billion in sales.
CoStar Group (CSGP) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
CoStar (CSGP) delivered earnings and revenue surprises of 7.02% and 1.11%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Akamai (AKAM) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Benefits from robust adoption of security solutions and solid traction for OTT video, triggered by coronavirus-led stay-at-home-wave, are likely to get reflected in Akamai's (AKAM) Q1 results.
SAIC or CSGP: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SAIC vs. CSGP: Which Stock Is the Better Value Option?
INFY vs. CSGP: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
INFY vs. CSGP: Which Stock Is the Better Value Option?
CoStar Group (CSGP) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
CoStar (CSGP) delivered earnings and revenue surprises of 7.63% and 3.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
5 Red Hot Stocks That Drove Nasdaq ETF to New Highs
by Sweta Killa
The Nasdaq Composite Index reached another all-time high driven by China's stimulus measures.
INFY vs. CSGP: Which Stock Is the Better Value Option?
by Zacks Equity Research
INFY vs. CSGP: Which Stock Is the Better Value Option?
Will Macerich's (MAC) Efforts Paint a Brighter Picture in 2020?
by Devyani Chamria
Though Macerich's (MAC) share-price performance has been disappointing in 2019, it is undertaking all appropriate measures to turn around tables in the upcoming year.
SAIC vs. CSGP: Which Stock Is the Better Value Option?
by Zacks Equity Research
SAIC vs. CSGP: Which Stock Is the Better Value Option?
New Strong Sell Stocks for November 4th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Technology Stock Q3 Earnings Due on Oct 22: TXN, SNAP & More
by Zacks Equity Research
Let's focus on some technology stocks like Texas Instruments (TXN), Snap (SNAP), CoStar Group (CSGP) and others that are slated to report third-quarter results on Oct 22.
SAIC vs. CSGP: Which Stock Is the Better Value Option?
by Zacks Equity Research
SAIC vs. CSGP: Which Stock Is the Better Value Option?
CTG vs. CSGP: Which Stock Is the Better Value Option?
by Zacks Equity Research
CTG vs. CSGP: Which Stock Is the Better Value Option?
CoStar Group (CSGP) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CoStar (CSGP) delivered earnings and revenue surprises of 11.50% and 2.28%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
CoStar Group (CSGP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CoStar (CSGP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
INFY vs. CSGP: Which Stock Is the Better Value Option?
by Zacks Equity Research
INFY vs. CSGP: Which Stock Is the Better Value Option?
SAIC vs. CSGP: Which Stock Is the Better Value Option?
by Zacks Equity Research
SAIC vs. CSGP: Which Stock Is the Better Value Option?
CoStar Group (CSGP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CoStar (CSGP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DELL vs. CSGP: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DELL vs. CSGP: Which Stock Is the Better Value Option?
DELL or CSGP: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DELL vs. CSGP: Which Stock Is the Better Value Option?
DELL or CSGP: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DELL vs. CSGP: Which Stock Is the Better Value Option?